ArticleTravel medicine and infectious disease2026
Epidemiological comparison of international travel-associated and domestically acquired Campylobacter, Salmonella, and Shigella infections reported to Foodborne Diseases Active Surveillance Network (FoodNet), 2010-2019.
Article in Travel medicine and infectious disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundA 2004-2009 analysis found that 13% of enteric illnesses reported in the United States were associated with international travel, with >90% caused by Campylobacter, Salmonella, or Shigella. This analysis characterizes the epidemiology of travel-associated campylobacteriosis, salmonellosis, and shigellosis in the FoodNet catchment during 2010-2019.
methodsWe analyzed FoodNet surveillance data for laboratory-confirmed infections during 2010-2019. Characteristics of travel-associated and domestically acquired infections were compared between world regions using incidence rate ratios (IRRs) and counterfactual random forest (CFRF) methods.
resultsDuring 2010-2019, 61,397 Campylobacter, 63,823 Salmonella, and 19,141 Shigella infections were reported. Among people with known travel status, 16%, 11%, and 15% of Campylobacter, Salmonella, and Shigella infections were travel-associated. Incidence of travel-associated campylobacteriosis, salmonellosis and shigellosis increased from 2004 to 2009 to 2010-2014 and from 2010 to 2014 to 2015-2019. More travelers reported visiting Latin America and the Caribbean (2010-2014: 44%; 2015-2019: 45%) but illness incidence was highest among travelers to Africa (2010-2014: 49.8 per 100,000; 2015-2019: 57.8 per 100,000). Demographic and clinical characteristics of people with travel-associated versus domestically acquired infections differed consistently across the three illnesses. Odds of reporting international travel were higher among urban versus rural residents, among people with mild versus severe illness, and among people diagnosed using culture-independent versus culture-based tests.
conclusionsThese findings underscore the importance of collecting travel history during clinical encounters and enteric disease investigations. Findings can help inform public health messaging and enteric disease prevention strategies provided to international travelers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.